MaxCyte Inc (MXCT) — Capital Reinvestment Ratio

Latest as of December 2023: 0.93x

MaxCyte Inc (MXCT) has a Capital Reinvestment Ratio of 0.93x as of December 2023, meaning it reinvests 1% of its operating cash flow ($981.70K) in capital expenditures ($914.80K). See MXCT net asset quality score to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.93x

Capex / Operating Cash Flow

Operating Cash Flow

$981.70K

USD

Capital Expenditures

$914.80K

USD

Data as of

Dec 2023

Most recent filing

Annual Capital Reinvestment Ratio for MaxCyte Inc (None–None)

Year-by-year Capital Reinvestment Ratio for MaxCyte Inc from None to None. For live market cap and broader valuation context, see MaxCyte Inc stock valuation.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow